CAR-T cell therapy and antibody-drug conjugates are two promising innovative immunotherapy approaches, but amongst all of the recent news and publications, it can be challenging to stay ahead of the emerging trends.  This idea in brief is a quick executive summary that identifies emerging trends, new opportunities, and key players in the immuno-oncology landscape.  Discover new modalities, checkpoint inhibitors, biomarkers, and targets that are growing quickly in our latest executive summary.  Download and share here: